You just read:

Lexicon Pharmaceuticals Acquires Exclusive Rights To Development Candidate For Neuropathic Pain From Its Alliance With Bristol-Myers Squibb

News provided by

Lexicon Pharmaceuticals, Inc.

07 Nov, 2016, 07:00 ET